Anti‐inflammatory effects of haptoglobin on LPS ‐stimulated macrophages: Role of HMGB1 signaling and implications in chronic wound healing

2020 ◽  
Vol 28 (4) ◽  
pp. 493-505
Author(s):  
Paulina Krzyszczyk ◽  
Hwan June Kang ◽  
Suneel Kumar ◽  
Yixin Meng ◽  
Maurice D. O'Reggio ◽  
...  
2015 ◽  
Vol 6 (1) ◽  
Author(s):  
Luis Rodriguez-Menocal ◽  
Shahjahan Shareef ◽  
Marcela Salgado ◽  
Arsalan Shabbir ◽  
Evangelos Van Badiavas

2015 ◽  
Vol 2 (5) ◽  
pp. 243 ◽  
Author(s):  
Pramod Kumar ◽  
Sudesh Kumar ◽  
EchalasaraGovindarama Padmanabha Udupa ◽  
Udaya Kumar ◽  
Pragna Rao ◽  
...  

Author(s):  
Mimansa Kandhwal ◽  
Tapan Behl ◽  
Arun Kumar ◽  
Sandeep Arora

: Nitric oxide (NO) is a promising pharmaceutical component that has vasodilator, antibacterial and wound healing activity. Chronic ulcers are non-healing disorders that are generally associated with distortion of lower limbs. Among the severe consequence’s derivative of these diseases, are the problems of chronic wound progression. NO which is categorized as smallest gaseous neurotransmitter has beneficial effects in different phases of chronic inflammation. Defensive mechanism of NO is found useful in several severe conditions such as gestational healing, gastrointestinal healing and diabetic healing. The current review presents up to date collection of literature about role of NO in chronic ulcers due to the prevalence of diabetes, DPN, and diabetic foot ulcers, and because of the lack of available effective treatments to directly address the pathology contributing to these conditions, novel treatments are being sought. This review also collects the information about deficiency of NO synthase in diabetic patients leads to a lack of vascularization of the peripheral nerves, which causes diabetic neuropathy; and this could be treated with vasodilators such as nitric oxide. Apart from pharmacological mechanism of NO, the article also reviewed and analyzed to elucidate the potential of a transdermal delivery of NO for the treatment of chronic ulcers.


2020 ◽  
Vol 21 (13) ◽  
pp. 1301-1312 ◽  
Author(s):  
Sandeep K. Shukla ◽  
Ajay K. Sharma ◽  
Vanya Gupta ◽  
Aman Kalonia ◽  
Priyanka Shaw

: Wound research is an evolving science trying to unfold the complex untold mechanisms behind the wound healing cascade. In particular, interest is growing regarding the role of microorganisms in both acute and chronic wound healing. Microbial burden plays an important role in the persistence of chronic wounds, ultimately resulting in delayed wound healing. It is therefore important for clinicians to understand the evolution of infection science and its various etiologies. Therefore, to understand the role of bacterial biofilm in chronic wound pathogenesis, various in vitro and in vivo models are required to investigate biofilms in wound-like settings. Infection models should be refined comprising an important signet of biofilms. These models are eminent for translational research to obtain data for designing an improved wound care formulation. However, all the existing models possess limitations and do not fit properly in the model frame for developing wound care agents. Among various impediments, one of the major drawbacks of such models is that the wound they possess does not mimic the wound a human develops. Therefore, a novel wound infection model is required which can imitate the human wounds. : This review article mainly discusses various in vitro and in vivo models showing microbial colonization, their advantages and challenges. Apart from these models, there are also present ex vivo wound infection models, but this review mainly focused on various in vitro and in vivo models available for studying wound infection in controlled conditions. This information might be useful in designing an ideal wound infection model for developing an effective wound healing formulation.


2018 ◽  
Vol 9 ◽  
Author(s):  
Paulina Krzyszczyk ◽  
Rene Schloss ◽  
Andre Palmer ◽  
François Berthiaume
Keyword(s):  

Vitamin C ◽  
2020 ◽  
pp. 161-179
Author(s):  
Juliet M. Pullar ◽  
Margreet C.M. Vissers

2012 ◽  
Vol 7 (1) ◽  
Author(s):  
Ruby Riana Asparini

Heparin was initially used in small doses as an anticoagulant in the treatment of burns. It turned out that in addition to the anticoagulant, heparin in larger doses can be used as an anti-inflammatory, accelerate angiogenesis (Polykratis, et al., 2004), cell growth and development (Sasisekharan and Venkataraman, 2000) so as to accelerate wound healing (Saliba, 2001; Galvan , 1996). In some countries heparin has been used as a standard therapy treatment of burns (Saliba, 2001). Heparin is one of highest endogenous glycosaminoglycans (GAGs) besides heparan sulfate (HS), keratin sulfate, dermatan sulfate, chondroitin 4-sulfate, chondroitinHS-6-sulfate and hyaluronic acid. heparin are the most acid and are highly sulfated, is the most GAGs widely used in burns as anti-inflammatory, to reduce edema, enhance angiogenesis and accelerate epitelialization (Saliba, 2001). Several studies have revealed the role of heparin in the treatment of burns. Keywords : Heparin, angiogenesis, epitelialization, treatment of burns


Sign in / Sign up

Export Citation Format

Share Document